Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Shares of Oracle Corporation ORCL rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fiscal third quarter.

Oracle’s third-quarter revenue increased 7% year-over-year to $13.3 billion, which missed the consensus estimate of $13.306 billion, according to Benzinga Pro. The company reported quarterly earnings of $1.41 per share, which beat average estimates of $1.38 per share.

Oracle shares jumped 13.4% to $129.46 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

Singularity Future Technology Ltd. SGLY gained 88.6% to $5.94 in pre-market trading after gaining over 6% on Monday.
Nukkleus Inc. NUKK shares rose 87.8% to $2.16 in pre-market trading after surging over 43% on Monday.
ClearOne, Inc. CLRO rose 74.4% to $1.58 in pre-market trading. ClearOne announced a special one-time cash dividend of 50 cents per share.
Assure Holdings Corp. IONM gained 49.6% to $0.49 in pre-market trading. Assure Holdings entered into an agreement to sell certain of its assets to MPOWERHealth for up to $4.5 million.
Gaucho Group Holdings, Inc. VINO climbed 31.4% to $0.71 in pre-market trading.
Heritage Insurance Holdings, Inc. HRTG shares gained 24.6% to $8.91 in pre-market trading following better-than-expected fourth-quarter results.
Nexalin Technology, Inc. NXL shares gained 18.7% to $0.5010 in pre-market trading after falling 12% on Monday. Nexalin Technology recently announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.
ATRenew Inc. RERE gained 15.1% to $1.37 in pre-market trading after the company reported fourth-quarter results and announced a $20 million share repurchase program.
MINISO Group Holding Limited MNSO shares gained 15% to $20.61 in pre-market trading after posting stronger-than-expected quarterly earnings.

Losers

Renalytix Plc RNLX fell 19.3% to $0.92 pre-market trading after gaining around 5% on Monday. Renalytix recently received an unsolicited acquisition approach from a large, publicly-listed strategic diagnostics company and is evaluating an acquisition of the entire issued, and to be issued, the share capital of the company.
CytomX Therapeutics, Inc. CTMX shares dipped 18.3% to $2.05 in pre-market trading following fourth-quarter results.
ACADIA Pharmaceuticals Inc ACAD fell 17.4% to $19.93 in pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint.
Finch Therapeutics Group, Inc. FNCH dipped 16.5% to $2.85 in pre-market trading after jumping over 36% on Monday.
Snow Lake Resources Ltd. LITM fell 13% to $0.80 pre-market trading after declining around 6% on Monday.
Solidion Technology Inc. STI fell 12.6% to $1.53 in pre-market trading after jumping 124% on Monday.
Safe and Green Development Corporation SGD declined 12.1% to $1.02 in pre-market trading after falling over 6% on Monday.
Kidpik Corp. PIK shares tumbled 10.8% to $4.34 after surging 80% on Monday.
Marpai, Inc. MRAI shares tumbled 10.2% to $1.76 in pre-market trading after gaining over 11% on Monday. Marpai shares are trading higher after the company reported better-than-expected preliminary Q4 net revenue results. Also, the company announced an "Off-Cycle" new client agreement.
Ocular Therapeutix, Inc. OCUL shares fell 5.9% to $9.16 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.